Oncotelic Therapeutics, Inc. (OTLC): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2015-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$13.0K
Year ended 2015-12-31
$109.0K2009-12-31: $109.0K2014-12-31: $17.0K2015-12-31: $13.0K$13.0K
2009-12-31 Capital Expenditures (USD) 2015-12-31
Period endedCapital ExpendituresChange YoYSource filing
2015-12-31$13.0K-23.5%2017-03-30, From 2015-01-01
2014-12-31$17.0Kn/a2016-03-25, From 2014-01-01
No annual figure between 2009-12-31 and 2014-12-31.
2009-12-31$109.0Kn/a2012-03-28, From 2009-01-01